Since PD-L1/PD-1 immune checkpoint blockade has transformed the treatment of many different cancers’ types and states, accumulating data also sustenance the basic concept that corticosteroid use at the same time of immune checkpoint therapy may give concerns. This evidence concerns the gene CD274 and cancer.